Drug Information

Drug General Information
Drug ID
D0P7DF
Former ID
DNC010110
Drug Name
1-[4-(4-Iodophenoxy)phenyl]piperazine
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530549]
Formula
C16H17IN2O
Canonical SMILES
C1CN(CCN1)C2=CC=C(C=C2)OC3=CC=C(C=C3)I
InChI
1S/C16H17IN2O/c17-13-1-5-15(6-2-13)20-16-7-3-14(4-8-16)19-11-9-18-10-12-19/h1-8,18H,9-12H2
InChIKey
AFIBQMXKOKSOEJ-UHFFFAOYSA-N
PubChem Compound ID
16039611
Target and Pathway
Target(s) Leukotriene A-4 hydrolase Target Info Inhibitor [530549]
BioCyc Pathway Leukotriene biosynthesis
KEGG Pathway Arachidonic acid metabolism
Metabolic pathways
PathWhiz Pathway Arachidonic Acid Metabolism
WikiPathways Arachidonic acid metabolism
Eicosanoid Synthesis
References
Ref 530549J Med Chem. 2010 Jan 28;53(2):573-85.Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.
Ref 530549J Med Chem. 2010 Jan 28;53(2):573-85.Discovery of 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}-1-pyrrolidinyl]butanoic acid (DG-051) as a novel leukotriene A4 hydrolase inhibitor of leukotriene B4 biosynthesis.